Terms: = Skin cancer AND CRTC1, Q6UUV9, 23373, ENSG00000105662, KIAA0616, TORC1, MECT1, WAMTP1, FLJ14027
32 results:
1. MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation.
Ko JS; Lemahieu J; Billings SD; Tirode F; Payton D; Boone B; Pissaloux D; de la Fouchardiere A
Mod Pathol; 2024 Apr; 37(4):100438. PubMed ID: 38278485
[TBL] [Abstract] [Full Text] [Related]
2. Cutaneous melanocytic tumor with crtc1::TRIM11 fusion: a case report.
Duan R; He X; Ma X; Huang F; Hu X
Diagn Pathol; 2024 Jan; 19(1):8. PubMed ID: 38184586
[TBL] [Abstract] [Full Text] [Related]
3. One step at a time: Melanocytic differentiation in fusion-driven cutaneous neoplasms.
Linos K
J Cutan Pathol; 2023 Dec; 50(12):1116-1118. PubMed ID: 37844955
[TBL] [Abstract] [Full Text] [Related]
4. Emerging mesenchymal tumour types and biases in the era of ubiquitous sequencing.
Towery EA; Papke DJ
J Clin Pathol; 2023 Dec; 76(12):802-812. PubMed ID: 37550012
[TBL] [Abstract] [Full Text] [Related]
5. Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey.
Kervarrec T; Tallet A; Macagno N; de la Fouchardière A; Pissaloux D; Tirode F; Bravo IG; Nicolas A; Baulande S; Sohier P; Balme B; Osio A; Jullie ML; Moulonguet I; Bonsang B; Tournier E; Herfs M; Frouin E; Zidan A; Calonje E; Berthon P; Touzé A; Seris A; Mortier L; Jouary T; Cribier B; Battistella M
Am J Surg Pathol; 2023 Oct; 47(10):1096-1107. PubMed ID: 37505808
[TBL] [Abstract] [Full Text] [Related]
6. Primary mucoepidermoid carcinoma of the external auditory canal with a crtc1::MAML2 fusion: A case report and a review of literature.
De la Sancha C; Kuhar M; Kraft A; Alomari AK
J Cutan Pathol; 2023 Nov; 50(11):947-950. PubMed ID: 37394842
[TBL] [Abstract] [Full Text] [Related]
7. Gene fusions in superficial mesenchymal neoplasms: Emerging entities and useful diagnostic adjuncts.
Fischer GM; Papke DJ
Semin Diagn Pathol; 2023 Jul; 40(4):246-257. PubMed ID: 37156707
[TBL] [Abstract] [Full Text] [Related]
8. Cutaneous Melanocytic Tumor With crtc1::TRIM11 Translocation : An Emerging Entity Analyzed in a Series of 41 Cases.
Hanna J; Ko JS; Billings SD; Boivin F; Beaudoux O; Pissaloux D; Tirode F; Laga A; Fletcher CDM; de la Fouchardiere A
Am J Surg Pathol; 2022 Nov; 46(11):1457-1466. PubMed ID: 35993578
[TBL] [Abstract] [Full Text] [Related]
9. MAML2 Gene Rearrangement Occurs in Nearly All Hidradenomas: A Reappraisal in a Series of 20 Cases.
Russell-Goldman E; Hanna J
Am J Dermatopathol; 2022 Nov; 44(11):806-811. PubMed ID: 35925563
[TBL] [Abstract] [Full Text] [Related]
10. Cutaneous melanocytic tumor with crtc1::TRIM11 fusion and prominent epidermal involvement: A case report.
Vest BE; Harview CL; Liu V; Swick BL; Berrebi KG; Olivares S; Stone MS; Sargen MR; Gerami P
J Cutan Pathol; 2022 Dec; 49(12):1025-1030. PubMed ID: 35751643
[TBL] [Abstract] [Full Text] [Related]
11. Dermal melanocytic tumor with crtc1-TRIM11 fusion: Report of two additional cases with review of the literature of an emerging entity.
Parra O; Bridge JA; Busam KJ; Shalin SC; Linos K
J Cutan Pathol; 2021 Jul; 48(7):915-924. PubMed ID: 33586183
[TBL] [Abstract] [Full Text] [Related]
12. A case report of cutaneous melanocytoma with crtc1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?
Kashima J; Motoi T; Nishimaki M; Hayashi Y; Ogawa M; Kato I; Yamada R; Tonooka A; Horiguchi SI; Funata N; Hishima T; Yoshino K
Pathol Int; 2019 Aug; 69(8):496-501. PubMed ID: 31276279
[TBL] [Abstract] [Full Text] [Related]
13. crtc1-TRIM11 fusion defined melanocytic tumors: A series of four cases.
Ko JS; Wang L; Billings SD; Pissaloux D; Tirode F; Berry R; De La Fouchardiere A
J Cutan Pathol; 2019 Nov; 46(11):810-818. PubMed ID: 31237704
[TBL] [Abstract] [Full Text] [Related]
14. Cutaneous Melanocytoma With crtc1-TRIM11 Fusion: Report of 5 Cases Resembling Clear Cell Sarcoma.
Cellier L; Perron E; Pissaloux D; Karanian M; Haddad V; Alberti L; de la Fouchardière A
Am J Surg Pathol; 2018 Mar; 42(3):382-391. PubMed ID: 29240581
[TBL] [Abstract] [Full Text] [Related]
15. Ceritinib Enhances the Efficacy of Trametinib in
Verduzco D; Kuenzi BM; Kinose F; Sondak VK; Eroglu Z; Rix U; Smalley KSM
Mol Cancer Ther; 2018 Jan; 17(1):73-83. PubMed ID: 29133622
[TBL] [Abstract] [Full Text] [Related]
16. A novel fusion gene CRTC3-MAML2 in hidradenoma: histopathological significance.
Kuma Y; Yamada Y; Yamamoto H; Kohashi K; Ito T; Furue M; Oda Y
Hum Pathol; 2017 Dec; 70():55-61. PubMed ID: 29079171
[TBL] [Abstract] [Full Text] [Related]
17. Autophagy gene ATG7 regulates ultraviolet radiation-induced inflammation and skin tumorigenesis.
Qiang L; Sample A; Shea CR; Soltani K; Macleod KF; He YY
Autophagy; 2017; 13(12):2086-2103. PubMed ID: 28933598
[TBL] [Abstract] [Full Text] [Related]
18. Cutaneous hidradenoma: a study of 21 neoplasms revealing neither correlation between the cellular composition and crtc1-MAML2 fusions nor presence of CRTC3-MAML2 fusions.
Kyrpychova L; Kacerovska D; Vanecek T; Grossmann P; Michal M; Kerl K; Kazakov DV
Ann Diagn Pathol; 2016 Aug; 23():8-13. PubMed ID: 27402217
[TBL] [Abstract] [Full Text] [Related]
19. Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth.
Kannan A; Lin Z; Shao Q; Zhao S; Fang B; Moreno MA; Vural E; Stack BC; Suen JY; Kannan K; Gao L
Oncotarget; 2016 Feb; 7(6):6576-92. PubMed ID: 26536665
[TBL] [Abstract] [Full Text] [Related]
20. Mitf is a master regulator of the v-ATPase, forming a control module for cellular homeostasis with v-ATPase and torc1.
Zhang T; Zhou Q; Ogmundsdottir MH; Möller K; Siddaway R; Larue L; Hsing M; Kong SW; Goding CR; Palsson A; Steingrimsson E; Pignoni F
J Cell Sci; 2015 Aug; 128(15):2938-50. PubMed ID: 26092939
[TBL] [Abstract] [Full Text] [Related]
[Next]
